Kennedy won Senate confirmation to his job, in part, by promising not to change the nation’s vaccine schedule. Since taking ...

The Trump administration on Monday announced federal officials are launching investigations into Harvard University and the ...

At the insistence of Justice Neil Gorsuch, she withdrew the allegation that the other side had lied but held firm to the ...

The coal industry once provided more than half of U.S. electricity production. But it has been in steep decline for decades ...

Novavax is working with the FDA to meet additional requirements and hopes to secure full approval as soon as possible.

Rep. Alexandria Ocasio-Cortez, D-N.Y., ran against Connolly for the job but was defeated as the majority of Democrats opted ...

Novavax has not received an official response from the FDA related to the status of the BLA. The BLA was based on data from a phase III study, which showed the vaccine was safe and effective for ...

Shares of Novavax (NVAX) are under pressure on Thursday ... composition as the reason for the push back, adding that the FDA is “shifting our priorities to multiple-antigen vaccines.” ...

When asked if the delay resulted from "personnel being shuffled" at the FDA, Kennedy attributed it to the vaccine's composition. He said Novavax's single antigen approach "has never worked" for ...

The FDA gave full approval to COVID-19 shots from ... PRICE ACTION: In Thursday morning trading, shares of Novavax have dropped over 24% to $5.13. Published first on TheFly – the ultimate ...

Beyond the pending Novavax approval, the FDA must in the coming weeks advise Covid vaccine manufacturers on how to update their shots for the 2025-2026 respiratory season. The agency is also ...